Shuttle Pharmaceuticals Holdings, Inc. (SHPH) SEC Filings — 2025

Filings

• Shuttle Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 29, 2025
• Shuttle Pharma Pivots to AI Drug Discovery, Discontinues Clinical Trials — S-1/A · Dec 11, 2025
• Shuttle Pharmaceuticals Holdings, Inc. 8-K Filing — 8-K · Nov 28, 2025
• Shuttle Pharmaceuticals Enters Material Agreement, Completes Acquisition — 8-K · Nov 26, 2025
• Shuttle Pharmaceuticals Announces Agreement Changes and Exit Costs — 8-K · Nov 21, 2025
• Shuttle Pharma Files S-1 for Resale of 625K Shares After $2.5M Private Placement — S-1 · Nov 18, 2025
• Shuttle Pharmaceuticals Faces Delisting Concerns — 8-K · Nov 17, 2025
• Shuttle Pharma's Losses Mount Amidst Cash Crunch, Strategic Acquisition — 10-Q · Nov 13, 2025
• Shuttle Pharmaceuticals Holdings, Inc. 8-K Filing — 8-K · Nov 7, 2025
• Shuttle Pharmaceuticals Reports Material Agreement Changes — 8-K · Oct 21, 2025
• Shuttle Pharmaceuticals Files 8-K for Material Agreement — 8-K · Sep 22, 2025
• Shuttle Pharmaceuticals Reports Director and Officer Changes — 8-K · Sep 18, 2025
• Shuttle Pharmaceuticals Files 8-K on Officer/Director Changes — 8-K · Sep 17, 2025
• Shuttle Pharmaceuticals Files 8-K on Officer/Director Changes — 8-K · Sep 8, 2025
• Shuttle Pharmaceuticals Reports Leadership and Compensation Changes — 8-K · Sep 5, 2025
• Shuttle Pharma's Losses Mount Amid Soaring R&D, G&A Costs — 10-Q · Aug 13, 2025
• Shuttle Pharma Files S-1 for Future Securities Offering — S-1 · Aug 5, 2025
• Shuttle Pharma Appoints New CMO, Elects New Director — 8-K · Jul 30, 2025
• Shuttle Pharmaceuticals Files 8-K on Equity Sales — 8-K · Jun 25, 2025
• Shuttle Pharmaceuticals Reports Director/Officer Changes — 8-K · May 28, 2025
• Shuttle Pharmaceuticals Reports Director/Officer Changes & Shareholder Votes — 8-K · May 15, 2025
• Shuttle Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 8, 2025
• Shuttle Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · May 6, 2025
• Shuttle Pharmaceuticals Files 8-K — 8-K · Apr 21, 2025
• Shuttle Pharmaceuticals Files 8-K — 8-K · Apr 10, 2025
• Shuttle Pharmaceuticals Enters Material Definitive Agreement — 8-K · Apr 4, 2025
• Shuttle Pharmaceuticals Files 8-K: Agreements, Personnel Changes — 8-K · Mar 31, 2025
• Shuttle Pharmaceuticals Enters Material Definitive Agreement — 8-K · Mar 25, 2025
• Shuttle Pharmaceuticals Files 8-K, Faces Listing Concerns — 8-K · Mar 13, 2025
• Shuttle Pharmaceuticals Files 8-K: Director Changes & Compensation Updates — 8-K · Mar 12, 2025
• Shuttle Pharmaceuticals Files S-1/A Amendment — S-1/A · Mar 5, 2025
• Shuttle Pharmaceuticals Files 8-K on Agreements and Personnel Changes — 8-K · Feb 28, 2025
• Shuttle Pharmaceuticals Enters Material Definitive Agreement — 8-K · Feb 27, 2025
• Shuttle Pharmaceuticals Files 2024 10-K — 10-K · Feb 26, 2025
• Shuttle Pharmaceuticals Files S-1 for Securities Registration — S-1 · Feb 13, 2025
• Shuttle Pharmaceuticals Enters Material Definitive Agreement — 8-K · Jan 28, 2025
• Shuttle Pharmaceuticals Files 8-K — 8-K · Jan 21, 2025
• Shuttle Pharmaceuticals Files S-1 for Securities Offering — S-1 · Jan 15, 2025
• Shuttle Pharmaceuticals Files 8-K Amid Listing Concerns — 8-K · Jan 7, 2025